JLL secures manufacturing facility for WuXi Biologics in Cranbury

JLL announced on Friday it has secured a new lease for WuXi Biologics in Cranbury ⁠— its third location in the United States.

The global provider of biologics technology signed a 10-year lease for the entire 68,000-square-foot clinical manufacturing facility at 7 Clarke Drive from building owner Cedar Brook Corporate Center.

WuXi was represented by JLL’s Robert Ryan and John Buckley, both executive vice presidents.

“WuXi Biologics continues to develop its global supply chain network,” Ryan said. “The Cranbury location offers the leading global CDMO tremendous access to New Jersey’s highly trained workforce and leading scientists’ pool.”

The building, which was constructed in 1998, is located within the Cedar Brook Corporate Center, a 1.2 million-square-foot office and technology park on 150 acres. It offers office space, a research and development laboratory and biologics manufacturing. The tenant plans to equip the building with process development and quality control laboratories.

WuXi has other facilities in Worcester, Massachusetts and King of Prussia, Pennsylvania. Its newest facility is located within close access to Route 130 and the New Jersey Turnpike.